Volume 66, Issue 3, Pages (March 2017)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Volume 67, Issue 3, Pages (September 2017)
Volume 61, Issue 2, Pages (August 2014)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Volume 42, Issue 4, Pages (April 2005)
Inflammasomes in liver diseases
Patients With NASH and Cryptogenic Cirrhosis Are Less Likely Than Those With Hepatitis C to Receive Liver Transplants  Jacqueline G. O'Leary, Carmen Landaverde,
Volume 50, Issue 4, Pages (April 2009)
MELD: the holy grail of organ allocation?
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies  Gennaro D'Amico, Guadalupe Garcia-Tsao, Luigi.
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis  Wichit Srikureja,
Volume 68, Issue 5, Pages (May 2018)
Volume 42, Issue 6, Pages (June 2005)
Volume 61, Issue 6, Pages (December 2014)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Immigration and viral hepatitis
Marcus-Alexander Wörns, Peter Robert Galle  Journal of Hepatology 
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Living donor liver transplantation: is the hype over?
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Reply to: “DCD consensus and futility in liver transplantation”
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
Volume 58, Issue 3, Pages (March 2013)
Mauro Bernardi, Stefano Gitto, Maurizio Biselli  Journal of Hepatology 
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Volume 44, Issue 1, Pages (January 2006)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 58, Issue 3, Pages (March 2013)
Volume 62, Issue 3, Pages (March 2015)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Autophagy in the liver Journal of Hepatology
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
Volume 55, Issue 2, Pages (August 2011)
Who should get a liver graft?
Volume 44, Issue 4, Pages (April 2006)
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 41, Issue 4, Pages (October 2004)
Volume 50, Issue 4, Pages (April 2009)
Monogenic diseases that can be cured by liver transplantation
Immigration and viral hepatitis
Evolution of liver transplantation for hepatocellular carcinoma
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
The impact of intestinal microflora on serum bilirubin levels
Volume 63, Issue 1, Pages (July 2015)
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice  Paolo Angeli, Pere Gines 
Volume 66, Issue 3, Pages (March 2017)
Volume 62, Issue 3, Pages (March 2015)
New trials and results in systemic treatment of HCC
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Volume 50, Issue 1, Pages 4-6 (January 2009)
The relationship between age and fat infiltration in liver and muscle
Patients With NASH and Cryptogenic Cirrhosis Are Less Likely Than Those With Hepatitis C to Receive Liver Transplants  Jacqueline G. O'Leary, Carmen Landaverde,
MELD: the holy grail of organ allocation?
Volume 70, Issue 5, Pages (May 2019)
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Volume 66, Issue 3, Pages 552-559 (March 2017) Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC  Andrea Notarpaolo, Richard Layese, Paolo Magistri, Maria Gambato, Michele Colledan, Giulia Magini, Lucia Miglioresi, Alessandro Vitale, Giovanni Vennarecci, Cecilia D Ambrosio, Patrizia Burra, Fabrizio Di Benedetto, Stefano Fagiuoli, Marco Colasanti, Giuseppe Maria Ettorre, Arnoldo Andreoli, Umberto Cillo, Alexis Laurent, Sandrine Katsahian, Etienne Audureau, Françoise Roudot-Thoraval, Christophe Duvoux  Journal of Hepatology  Volume 66, Issue 3, Pages 552-559 (March 2017) DOI: 10.1016/j.jhep.2016.10.038 Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Risk of recurrence according to pre-LT AFP thresholds as defined in the AFP model. (This figure appears in colour on the web.) Journal of Hepatology 2017 66, 552-559DOI: (10.1016/j.jhep.2016.10.038) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Overall probabilities of recurrence and survival. Probabilities according to the AFP score cut-off of 2 (A and B) or Milan criteria (C and D). (This figure appears in colour on the web.) Journal of Hepatology 2017 66, 552-559DOI: (10.1016/j.jhep.2016.10.038) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Probabilities of death not related to HCC recurrence as assessed by competing risk analysis. Data according to the AFP model. (This figure appears in colour on the web.) Journal of Hepatology 2017 66, 552-559DOI: (10.1016/j.jhep.2016.10.038) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 4 Probabilities of recurrence according to the AFP score cut-off of 2, in patients fulfilling or not Milan criteria. (A) Patients within Milan criteria. (B) Patients beyond Milan criteria. (This figure appears in colour on the web.) Journal of Hepatology 2017 66, 552-559DOI: (10.1016/j.jhep.2016.10.038) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 5 HCC recurrence in hepatitis populations. Probabilities of recurrence (A and C) and overall survival (B and D), according to the AFP score cut-off of 2 in the HCV population (A and B) and in the HBV population (C and D). (This figure appears in colour on the web.) Journal of Hepatology 2017 66, 552-559DOI: (10.1016/j.jhep.2016.10.038) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2017 66, 552-559DOI: (10. 1016/j. jhep. 2016. 10 Copyright © 2016 European Association for the Study of the Liver Terms and Conditions